Generating a Glioblastoma Rat Model
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 2:36 min • April 28th, 2025
Loading...
Overview
This article demonstrates the procedure for establishing a glioblastoma rat model by stereotactically injecting glioblastoma cells into the prefrontal cortex. The protocol enables researchers to create a reproducible in vivo model for studying glioblastoma progression and evaluating therapeutic interventions.
Key Study Components
Area of Science
- Neuroscience
- Cancer research
- Animal modeling
Background
- Glioblastoma is an aggressive brain tumor with poor prognosis.
- Animal models are essential for studying tumor biology and testing treatments.
- Stereotactic injection allows precise delivery of tumor cells into specific brain regions.
- Establishing a reliable glioblastoma model in rats facilitates translational research.
Purpose of Study
- To establish a reproducible glioblastoma rat model via stereotactic injection.
- To provide a detailed protocol for intracranial tumor cell implantation.
- To enable subsequent studies on tumor growth, invasion, and therapy response.
Methods Used
- Anesthetize a female Fisher F344 rat and confirm sedation.
- Shave the scalp, apply eye ointment, and secure the animal in a stereotactic frame.
- Disinfect the surgical site and make a midline scalp incision to expose the skull.
- Drill a 1 mm hole in the right frontal hemisphere (2 mm posterior, 2.5 mm lateral to bregma).
- Load a 29-gauge insulin syringe with 5 µL of glioblastoma cell suspension.
- Inject the cells 3 mm deep into the prefrontal cortex using a micro-syringe pump controller.
- Slowly withdraw the needle, seal the hole with bone wax, suture the incision, and disinfect.
- Maintain body temperature post-surgery with a red lamp and monitor until recovery.
Main Results
- Successful establishment of a glioblastoma model in rats.
- Injected tumor cells proliferate, infiltrate surrounding tissue, and induce angiogenesis.
- The model disrupts normal brain function, mimicking human glioblastoma pathology.
- Provides a platform for studying tumor progression and testing therapies.
Conclusions
- The described protocol enables reliable induction of glioblastoma in rats.
- Stereotactic injection ensures precise tumor cell placement and reproducibility.
- This model is valuable for preclinical research on glioblastoma biology and treatment.
Frequently Asked Questions
What type of rats are used in this glioblastoma model?
Female Fisher F344 rats, typically weighing around 170 grams, are used for the procedure.
How are glioblastoma cells introduced into the rat brain?
Cells are stereotactically injected into the prefrontal cortex using a 29-gauge insulin syringe and a micro-syringe pump controller.
What are the coordinates for the injection site?
The injection site is 2 mm posterior and 2.5 mm lateral to the bregma in the right frontal hemisphere, at a depth of 3 mm.
How is the surgical site managed post-injection?
The drilled hole is sealed with bone wax, the incision is sutured, and the area is disinfected with povidone iodine.
How is animal welfare maintained during and after the procedure?
Anesthesia is confirmed before surgery, eye ointment is applied, body temperature is maintained with a red lamp, and the animal is monitored until full recovery.
What is the purpose of this glioblastoma rat model?
The model allows researchers to study glioblastoma growth, invasion, and response to therapies in a controlled in vivo setting.
Executive Industry Relevance
Establishing a reproducible glioblastoma rat model enables rigorous preclinical evaluation of tumor biology and therapeutic interventions. This model supports predictive confidence in translational oncology by providing a controlled system for mechanistic de-risking and target validation. Its integration into discovery pipelines informs portfolio decisions and risk-adjusted advancement of glioblastoma therapies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of glioblastoma tumorigenesis and pathway involvement in a controlled in vivo context.
- Supports biological de-risking by modeling tumor proliferation, invasion, and angiogenesis.
- Facilitates functional target validation for candidate therapeutics in a disease-relevant system.
Screening & Assay Development
- Provides a validated animal model for downstream efficacy and pharmacodynamic studies.
- Supports assay standardization and reproducibility through precise stereotactic cell delivery.
- Enables quantitative assessment of tumor growth and response to interventions.
Translational & Preclinical Research
- Aligns with translational biomarker development by recapitulating key features of human glioblastoma.
- Ensures continuity from discovery through preclinical validation in oncology pipelines.
- Supports risk-adjusted advancement decisions based on in vivo efficacy and mechanistic insights.
Pipeline & Workflow Integration
This glioblastoma rat model is positioned at the interface of early discovery and preclinical research, enabling hypothesis testing and lead validation prior to clinical translation.
- Discovery Biology: Facilitates hypothesis-driven investigation of glioblastoma mechanisms and therapeutic targets.
- Screening: Provides a reproducible platform for evaluating compound efficacy and tumor response.
- Analytics: Enables quantitative measurement of tumor proliferation, invasion, and angiogenesis.
- Translational Research: Bridges discovery findings with preclinical validation in a disease-relevant context.
- Enterprise Reuse: Offers a standardized, reusable model for ongoing oncology research and portfolio evaluation.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in glioblastoma research.
- Operational Value: Standardizes tumor induction and supports reproducibility across studies.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency in oncology pipelines.
- Portfolio Impact: Enables risk-adjusted prioritization of glioblastoma therapeutic candidates.
Implementation Considerations
- Requires expertise in stereotactic surgery and animal model handling.
- Needs access to micro-syringe pump controllers and stereotactic frames.
- Demands rigorous cross-team standardization for reproducibility.
- Adaptation may be needed for different rat strains or tumor cell lines.
- Limitations include species-specific differences and ethical considerations in animal use.
Biopharma FAQs
Why does null hypothesis testing matter for glioblastoma model validation?
Null hypothesis testing ensures that observed tumor growth and invasion are attributable to the injected glioblastoma cells rather than procedural artifacts. This statistical rigor underpins confidence in model validity and supports robust target validation in preclinical oncology research.
How does independent variable isolation fit the stereotactic injection workflow?
Isolating the variable of glioblastoma cell injection allows researchers to attribute downstream tumor development specifically to the introduced cells. This isolation is critical for mechanistic de-risking and for establishing causality in therapeutic studies.
What do quantitative dependent variable measurements enable in this rat model?
Quantitative measurements of tumor proliferation, invasion, and angiogenesis enable objective comparison of therapeutic interventions and mechanistic studies. These outputs support data-driven decision-making and enhance predictive confidence in translational research.
Why are replication requirements important for cross-functional glioblastoma studies?
Replication ensures that tumor induction and progression are consistent across experiments and teams, supporting reproducibility and cross-functional collaboration. This reliability is essential for advancing candidates through the oncology pipeline with reduced biological risk.
What statistical analysis capabilities are required before implementing this glioblastoma model?
Robust statistical analysis is needed to assess tumor growth, invasion, and treatment effects, ensuring that findings are significant and reproducible. These capabilities underpin portfolio decisions and the translational value of preclinical glioblastoma research.
09:17
Bioluminescence Imaging of an Immunocompetent Animal Model for Glioblastoma
Related Videos
0 Views
09:36
Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
Related Videos
0 Views
07:57
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Related Videos
0 Views
10:13
Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Related Videos
0 Views
10:58
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Related Videos
0 Views
10:48
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Related Videos
0 Views
07:37
Translational Orthotopic Models of Glioblastoma Multiforme
Related Videos
0 Views
04:46
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
Related Videos
0 Views
09:02
Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
Related Videos
0 Views
05:39
Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
Related Videos
0 Views
Last updated: 1 August 2026